Boston Scientific (BSX) Operating Margin: History & Chart

Boston Scientific Corporation(BSX)

Medical - Devices · Marlborough, MA

$44.30-0.75 (-1.68%)

Delayed quote: Sep 15, 2026, 1:05 PM EDT

About Boston Scientific Corporation

Boston Scientific Corporation (BSX) operates as a global leader in medical technology, specializing in the design, manufacturing, and commercialization of innovative medical devices tailored for a diverse array of interventional medical specialties across the globe. Its business is strategically organized into three principal segments: MedSurg, Rhythm and Neuro, and Cardiovascular. Within these divisions, the company provides a comprehensive portfolio of solutions addressing various gastrointestinal and pulmonary ailments, as well as urological and pelvic health concerns. This extends to advanced implantable devices for managing cardiac rhythm disorders, such as cardioverter-defibrillators, cardiac resynchronization therapy devices, and pacemakers, complemented by remote patient management systems. Furthermore, Boston Scientific offers sophisticated technologies for diagnosing and treating complex heart rate and rhythm irregularities. These encompass 3-D cardiac mapping and navigation tools, along with a suite of specialized catheters (including ablation, diagnostic, mapping, and intracardiac ultrasound types), delivery sheaths, and related accessories. Its offerings also extend to neurological conditions, providing spinal cord stimulator systems for chronic pain management, indirect decompression systems, and deep brain stimulation systems. In the realm of interventional cardiology, the company's innovations include drug-eluting coronary stent systems designed for treating coronary artery disease, products for percutaneous coronary interventions to combat atherosclerosis, and intravascular imaging catheters (such as ultrasound and fractional flow reserve devices) for assessing coronary arteries, heart chambers, and peripheral vessels. It also develops structural heart therapies. Beyond this, Boston Scientific supplies an array of stents, balloon catheters, wires, and atherectomy systems for the treatment of arterial diseases. For venous conditions, it provides thrombectomy and acoustic pulse thrombolysis systems, alongside wires and stents. Critically, the company also contributes to cancer treatment through peripheral embolization devices, radioactive microspheres, various ablation systems (including cryotherapy), and micro and drainage catheters. The organization was established in 1979 and maintains its corporate headquarters in Marlborough, Massachusetts.

Marlborough, MA

59,000 employees

www.bostonscientific.com

Healthcare / Medical - Devices

Sector: Healthcare
Industry: Medical - Devices
CEO: Michael F. Mahoney

View full financials

BSX Operating Margin Metrics

OPERATING MARGIN

21.46%

OPERATING MARGIN AVG TTM

20.40%

OPERATING MARGIN AVG 3Y

17.77%

OPERATING MARGIN AVG 5Y

16.70%

OPERATING MARGIN AVG 10Y

16.18%

OPERATING MARGIN AVG 15Y

13.97%

OPERATING MARGIN AVG 20Y

13.00%

CURRENT VS TTM AVG

+5.22%

CURRENT VS 3Y AVG

+20.74%

CURRENT VS 5Y AVG

+28.49%

CURRENT VS 10Y AVG

+32.62%

CURRENT VS 15Y AVG

+53.62%

CURRENT VS 20Y AVG

+65.02%

SECTOR MEDIAN · HEALTHCARE

14.90%

median of 90 covered companies

CURRENT VS SECTOR MEDIAN

+44.03%

vs the sector median at left

NAME	MARKET CAP	OPERATING MARGIN	TTM	3Y	5Y
Boston Scientific Corporation (BSX)	$65.84B	21.46%	20.40%	17.77%	16.70%
Cencora, Inc. (COR)vs ›	$62.74B	1.30%	1.08%	1.06%	1.09%
Moderna, Inc. (MRNA)vs ›	$57.33B	-158.13%	-140.72%	-73.36%	-52.24%
Cigna Corporation (CI)vs ›	$76.63B	3.46%	3.56%	4.04%	4.30%
Cardinal Health, Inc. (CAH)vs ›	$54.24B	1.03%	1.02%	0.74%	0.49%
Regeneron Pharmaceuticals, Inc. (REGN)vs ›	$80.54B	25.56%	26.52%	32.61%	38.03%
Becton, Dickinson and Company (BDX)vs ›	$51.13B	9.83%	11.84%	11.67%	10.68%
Edwards Lifesciences Corporation (EW)vs ›	$49.32B	28.09%	26.16%	28.11%	28.79%
Humana Inc. (HUM)vs ›	$47.51B	1.39%	1.25%	2.37%	3.27%
Teva Pharmaceutical Industries Limited (TEVA)vs ›	$45.67B	11.45%	5.33%	-0.33%	-1.99%

NAME

MARKET CAP

OPERATING MARGIN

TTM

Boston Scientific Corporation (BSX)

$65.84B

21.46%

20.40%

17.77%

16.70%

Cencora, Inc. (COR)vs ›

$62.74B

1.30%

1.08%

1.06%

1.09%

Moderna, Inc. (MRNA)vs ›

$57.33B

-158.13%

-140.72%

-73.36%

-52.24%

Cigna Corporation (CI)vs ›

$76.63B

3.46%

3.56%

4.04%

4.30%

Cardinal Health, Inc. (CAH)vs ›

$54.24B

1.03%

1.02%

0.74%

0.49%

Regeneron Pharmaceuticals, Inc. (REGN)vs ›

$80.54B

25.56%

26.52%

32.61%

38.03%

Becton, Dickinson and Company (BDX)vs ›

$51.13B

9.83%

11.84%

11.67%

10.68%

Edwards Lifesciences Corporation (EW)vs ›

$49.32B

28.09%

26.16%

28.11%

28.79%

Humana Inc. (HUM)vs ›

$47.51B

1.39%

1.25%

2.37%

3.27%

Teva Pharmaceutical Industries Limited (TEVA)vs ›

$45.67B

11.45%

5.33%

-0.33%

-1.99%

Operating Margin FAQ

What is the operating margin for Boston Scientific Corporation (BSX)?

The operating margin for BSX stock is 21.46%.

Is Boston Scientific Corporation's operating margin high or low?

The operating margin of 21.46% is 28% above its 5-year average of 16.70%, near the high end of its 5-year range (12.91%–22.81%).

What is the TTM average operating margin for Boston Scientific Corporation (BSX)?

The TTM average operating margin for BSX stock is 20.40%.

What is the 3Y average operating margin for Boston Scientific Corporation (BSX)?

The 3Y average operating margin for BSX stock is 17.77%.

What is the 5Y average operating margin for Boston Scientific Corporation (BSX)?

The 5Y average operating margin for BSX stock is 16.70%.

What is the 10Y average operating margin for Boston Scientific Corporation (BSX)?

The 10Y average operating margin for BSX stock is 16.18%.

What is the 15Y average operating margin for Boston Scientific Corporation (BSX)?

The 15Y average operating margin for BSX stock is 13.97%.

What is the 20Y average operating margin for Boston Scientific Corporation (BSX)?

The 20Y average operating margin for BSX stock is 13.00%.

DATE	OPERATING MARGIN
2026-06-30	21.65%
2026-03-31	20.60%
2025-12-31	22.81%
2025-09-30	20.73%
2025-06-30	16.18%
2025-03-31	19.22%
2024-12-31	12.91%
2024-09-30	16.01%
2024-06-30	18.13%
2024-03-31	16.70%
2023-12-31	14.98%
2023-09-30	15.82%
2023-06-30	15.31%
2023-03-31	15.20%
2022-12-31	13.85%
2022-09-30	14.51%
2022-06-30	14.70%
2022-03-31	15.10%
2021-12-31	14.61%
2021-09-30	15.08%
2021-06-30	16.61%
2021-03-31	13.08%
2020-12-31	6.43%
2020-09-30	9.85%
2020-06-30	-3.05%
2020-03-31	8.77%
2019-12-31	14.08%
2019-09-30	14.67%
2019-06-30	16.38%
2019-03-31	17.21%
2018-12-31	16.56%
2018-09-30	17.18%
2018-06-30	17.95%
2018-03-31	19.21%
2017-12-31	18.44%
2017-09-30	16.92%
2017-06-30	17.50%
2017-03-31	14.26%
2016-12-31	14.51%
2016-09-30	15.96%
2016-06-30	-15.71%
2016-03-31	14.92%
2015-12-31	-13.70%
2015-09-30	-15.84%
2015-06-30	11.88%
2015-03-31	1.36%
2014-12-31	5.67%
2014-09-30	3.47%
2014-06-30	-3.68%
2014-03-31	11.10%
2013-12-31	6.91%
2013-09-30	5.94%
2013-06-30	12.16%
2013-03-31	-18.74%
2012-12-31	6.32%
2012-09-30	-37.75%
2012-06-30	-186.65%
2012-03-31	10.50%
2011-12-31	9.20%
2011-09-30	9.28%
2011-06-30	12.00%
2011-03-31	15.38%
2010-12-31	17.38%
2010-09-30	13.10%
2010-06-30	11.98%
2010-03-31	-75.82%
2009-12-31	-59.21%
2009-09-30	17.04%
2009-06-30	13.26%
2009-03-31	0.55%
2008-12-31	-120.73%
2008-09-30	1.42%
2008-06-30	14.97%
2008-03-31	28.35%
2007-12-31	-19.97%
2007-09-30	-7.18%
2007-06-30	13.52%
2007-03-31	13.52%
2006-12-31	13.75%
2006-09-30	9.62%
2006-06-30	-186.02%
2006-03-31	30.68%
2005-12-31	30.19%
2005-09-30	-22.24%
2005-06-30	20.16%
2005-03-31	31.76%
2004-12-31	31.50%
2004-09-30	24.16%
2004-06-30	30.68%
2004-03-31	24.40%
2003-12-31	20.87%
2003-09-30	19.75%
2003-06-30	20.26%
2003-03-31	19.21%
2002-12-31	19.29%
2002-09-30	34.07%

DATE

OPERATING MARGIN

2026-06-30

21.65%

2026-03-31

20.60%

2025-12-31

22.81%

2025-09-30

20.73%

2025-06-30

16.18%

2025-03-31

19.22%

2024-12-31

12.91%

2024-09-30

16.01%

2024-06-30

18.13%

2024-03-31

16.70%

2023-12-31

14.98%

2023-09-30

15.82%

2023-06-30

15.31%

2023-03-31

15.20%

2022-12-31

13.85%

2022-09-30

14.51%

2022-06-30

14.70%

2022-03-31

15.10%

2021-12-31

14.61%

2021-09-30

15.08%

2021-06-30

16.61%

2021-03-31

13.08%

2020-12-31

6.43%

2020-09-30

9.85%

2020-06-30

-3.05%

2020-03-31

8.77%

2019-12-31

14.08%

2019-09-30

14.67%

2019-06-30

16.38%

2019-03-31

17.21%

2018-12-31

16.56%

2018-09-30

17.18%

2018-06-30

17.95%

2018-03-31

19.21%

2017-12-31

18.44%

2017-09-30

16.92%

2017-06-30

17.50%

2017-03-31

14.26%

2016-12-31

14.51%

2016-09-30

15.96%

2016-06-30

-15.71%

2016-03-31

14.92%

2015-12-31

-13.70%

2015-09-30

-15.84%

2015-06-30

11.88%

2015-03-31

1.36%

2014-12-31

5.67%

2014-09-30

3.47%

2014-06-30

-3.68%

2014-03-31

11.10%

2013-12-31

6.91%

2013-09-30

5.94%

2013-06-30

12.16%

2013-03-31

-18.74%

2012-12-31

6.32%

2012-09-30

-37.75%

2012-06-30

-186.65%

2012-03-31

10.50%

2011-12-31

9.20%

2011-09-30

9.28%

2011-06-30

12.00%

2011-03-31

15.38%

2010-12-31

17.38%

2010-09-30

13.10%

2010-06-30

11.98%

2010-03-31

-75.82%

2009-12-31

-59.21%

2009-09-30

17.04%

2009-06-30

13.26%

2009-03-31

0.55%

2008-12-31

-120.73%

2008-09-30

1.42%

2008-06-30

14.97%

2008-03-31

28.35%

2007-12-31

-19.97%

2007-09-30

-7.18%

2007-06-30

13.52%

2007-03-31

13.52%

2006-12-31

13.75%

2006-09-30

9.62%

2006-06-30

-186.02%

2006-03-31

30.68%

2005-12-31

30.19%

2005-09-30

-22.24%

2005-06-30

20.16%

2005-03-31

31.76%

2004-12-31

31.50%

2004-09-30

24.16%

2004-06-30

30.68%

2004-03-31

24.40%

2003-12-31

20.87%

2003-09-30

19.75%

2003-06-30

20.26%

2003-03-31

19.21%

2002-12-31

19.29%

2002-09-30

34.07%

Operating Margin: 21.46%

BSX Operating Margin

BSX Average Operating Margin Chart

BSX Current vs Average Operating Margin Chart

BSX Operating Margin Metrics

BSX Competitors' Operating Margin

Operating Efficiency

Operating Margin Formula & Definition

Operating Margin FAQ

BSX Operating Margin History

Related Metrics